Immunisation against HPV in girls with intellectual disabilities
Immunisation against HPV in girls with intellectual disabilities
复制标题
DOI：
10.1136/archdischild-2013-305919
复制
发表时间：
2014-12-01
影响因子：
5.2
通讯作者：
Tuffrey, Catherine
中科院分区：
文献类型：
--
作者：
MacLeod, Rebecca;Tuffrey, Catherine
自2008年9月以来，在英国，作为儿童免疫接种计划的一部分，已向所有12-13岁的女孩常规提供人乳头瘤病毒（HPV）免疫接种。先前的研究表明，与非残疾同龄人相比，在智障儿童和青少年学校上学的儿童接受常规疫苗接种的可能性较小。1来自朴茨茅斯地区进行的审计的未发表数据表明HPV疫苗接种存在类似问题。本文探讨了我们对HPV感染的了解和智障人士面临的风险，以及为什么免疫率可能较低以及我们应该采取什么措施。
Since September 2008 in the UK, immunisation against human papillomavirus (HPV) has been routinely offered to all girls aged 12–13 years as part of the childhood immunisation programme. It has been shown in previous research, that children attending schools for children and young people with intellectual disability are less likely to receive routine vaccines compared with non-disabled peers. 1 Unpublished data from an audit carried out in the Portsmouth district suggests similar issues for HPV vaccination. This paper looks at what we know about HPV infection and the risks to individuals with intellectual disability, as well as why immunisation rates may be lower and what we should do about this.